Dr. Henry F. Vischer studied biology at Utrecht University. He then joined the neurobiology department at the Mount Sinai School of Medicine in New York (1997–1998) to investigate ligand-binding pockets of G protein-coupled receptors (GPCRs). His PhD project (1998–2003) at Utrecht University focused on cloning, profiling, and ligand-receptor interactions between gonadotropins and their cognate GPCRs. He was awarded the Organon Research Prize for Endocrinology (2003). As a postdoctoral fellow (2003–2008) in the Department of Medicinal Chemistry at the Vrije Universiteit Amsterdam he was involved in molecular GPCR pharmacology, signaling, and receptor–receptor interactions of (viral) chemokine receptors. He has obtained Netherlands Organisation for Scientific Research (NWO) Veni (2005), Netherlands Genomics Initiative (NGI) Horizon Breakthrough (2008), and NWO ECHO (2012) grants. In 2009, he was appointed assistant professor in the same department and currently focuses on molecular GPCR pharmacology, in particular biased signaling, receptor residence time, and multiplex biosensor assay development.
Dr. Henry F. Vischer studied biology at Utrecht University. He then joined the neurobiology department at the Mount Sinai School of Medicine in New York (1997–1998) to investigate ligand-binding pockets of G protein-coupled receptors (GPCRs). His PhD project (1998–2003) at Utrecht University focused on cloning, profiling, and ligand-receptor interactions between gonadotropins and their cognate GPCRs. He was awarded the Organon Research Prize for Endocrinology (2003). As a postdoctoral fellow (2003–2008) in the Department of Medicinal Chemistry at the Vrije Universiteit Amsterdam he was involved in molecular GPCR pharmacology, signaling, and receptor–receptor interactions of (viral) chemokine receptors. He has obtained Netherlands Organisation for Scientific Research (NWO) Veni (2005), Netherlands Genomics Initiative (NGI) Horizon Breakthrough (2008), and NWO ECHO (2012) grants. In 2009, he was appointed assistant professor in the same department and currently focuses on molecular GPCR pharmacology, in particular biased signaling, receptor residence time, and multiplex biosensor assay development.